Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives Consensus Recommendation of “Hold” from Brokerages
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) has been given a consensus recommendation of “Hold” by the ten brokerages that are presently covering the firm, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to […]
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) has been given a consensus recommendation of “Hold” by the ten brokerages that are presently covering the firm, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to […]
